MRSN Annual Working Capital
$150.42 M
-$77.27 M-33.94%
31 December 2023
Summary:
As of January 23, 2025, MRSN annual working capital is $150.42 million, with the most recent change of -$77.27 million (-33.94%) on December 31, 2023. During the last 3 years, it has fallen by -$78.16 million (-34.19%). MRSN annual working capital is now -34.19% below its all-time high of $228.58 million, reached on December 31, 2020.MRSN Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MRSN Quarterly Working Capital
$92.26 M
-$14.52 M-13.60%
30 September 2024
Summary:
As of January 23, 2025, MRSN quarterly working capital is $92.26 million, with the most recent change of -$14.52 million (-13.60%) on September 30, 2024. Over the past year, it has dropped by -$89.55 million (-49.26%). MRSN quarterly working capital is now -66.14% below its all-time high of $272.48 million, reached on June 30, 2020.MRSN Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MRSN Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -33.9% | -49.3% |
| 3 y3 years | -34.2% | -49.3% |
| 5 y5 years | +2982.4% | -49.3% |
MRSN Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -33.9% | +6.4% | -59.5% | at low |
| 5 y | 5-year | -34.2% | +94.7% | -66.1% | +46.9% |
| alltime | all time | -34.2% | +7350.2% | -66.1% | +1790.5% |
Mersana Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $92.26 M(-13.6%) |
| June 2024 | - | $106.78 M(-20.4%) |
| Mar 2024 | - | $134.13 M(-10.8%) |
| Dec 2023 | $150.42 M(-33.9%) | $150.42 M(-17.3%) |
| Sept 2023 | - | $181.81 M(-18.2%) |
| June 2023 | - | $222.17 M(+12.0%) |
| Mar 2023 | - | $198.41 M(-12.9%) |
| Dec 2022 | $227.69 M(+61.1%) | $227.69 M(+7.8%) |
| Sept 2022 | - | $211.24 M(+27.6%) |
| June 2022 | - | $165.61 M(-10.5%) |
| Mar 2022 | - | $185.01 M(+30.9%) |
| Dec 2021 | $141.38 M(-38.1%) | $141.38 M(-9.0%) |
| Sept 2021 | - | $155.33 M(-19.5%) |
| June 2021 | - | $192.96 M(-2.1%) |
| Mar 2021 | - | $197.03 M(-13.8%) |
| Dec 2020 | $228.58 M | $228.58 M(-10.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2020 | - | $253.86 M(-6.8%) |
| June 2020 | - | $272.48 M(+333.9%) |
| Mar 2020 | - | $62.80 M(-18.7%) |
| Dec 2019 | $77.26 M(+1483.1%) | $77.26 M(-16.3%) |
| Sept 2019 | - | $92.31 M(-14.3%) |
| June 2019 | - | $107.70 M(-9.1%) |
| Mar 2019 | - | $118.48 M(+2327.8%) |
| Dec 2018 | $4.88 M(-94.3%) | $4.88 M(-91.7%) |
| Sept 2018 | - | $58.61 M(-16.6%) |
| June 2018 | - | $70.31 M(-14.3%) |
| Mar 2018 | - | $82.02 M(-4.3%) |
| Dec 2017 | $85.66 M(+16.1%) | $85.66 M(-23.7%) |
| Sept 2017 | - | $112.21 M(+133.1%) |
| June 2017 | - | $48.13 M(-16.5%) |
| Mar 2017 | - | $57.66 M(-21.9%) |
| Dec 2016 | $73.79 M(+3554.6%) | $73.79 M |
| Dec 2015 | $2.02 M | - |
FAQ
- What is Mersana Therapeutics annual working capital?
- What is the all time high annual working capital for Mersana Therapeutics?
- What is Mersana Therapeutics annual working capital year-on-year change?
- What is Mersana Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Mersana Therapeutics?
- What is Mersana Therapeutics quarterly working capital year-on-year change?
What is Mersana Therapeutics annual working capital?
The current annual working capital of MRSN is $150.42 M
What is the all time high annual working capital for Mersana Therapeutics?
Mersana Therapeutics all-time high annual working capital is $228.58 M
What is Mersana Therapeutics annual working capital year-on-year change?
Over the past year, MRSN annual working capital has changed by -$77.27 M (-33.94%)
What is Mersana Therapeutics quarterly working capital?
The current quarterly working capital of MRSN is $92.26 M
What is the all time high quarterly working capital for Mersana Therapeutics?
Mersana Therapeutics all-time high quarterly working capital is $272.48 M
What is Mersana Therapeutics quarterly working capital year-on-year change?
Over the past year, MRSN quarterly working capital has changed by -$89.55 M (-49.26%)